TABLE I. Colony-Forming Assay From CD34 + Bone Marrow Cells Serum a BFU-E/10 2 CD34 + cells Control 1 50.2 ยฑ 4.6 Control 2 48.5 ยฑ 14.1 Before chemotherapy 24.4 ยฑ 6.2 b After chemotherapy 50.5 ยฑ 6.5 Values are means ยฑ SD of triplicate cultures. a Control 1; normal AB serum, Control 2; serum from a pa
Concurrent pernicious anemia and myelodysplastic syndrome
โ Scribed by Joseph J. Drabick; Brad J. Davis; John C. Byrd
- Book ID
- 105990087
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 21 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Myelodysplastic syndromes (MDS) may be associated with inflammatory bowel disease (IBD). We characterized the clinical features and outcomes of patients with concurrent IBD and MDS. Using a diagnostic index, we identified all patients with both IBD and MDS at our center between 1976 and 1997. We als
The case history of two sisters with pyridoxine-refractory familial sideroblastic anemia (FSA) is presented in which one developed a myelodysplastic syndrome (MDS) with monosomy for chromosome 5. Bone marrow examination of both patients at diagnosis showed erythroid hyperplasia with more than 50% ri